SELLAS Life Sciences Group, Inc. — 424B5 Filings
36 424B5 filings on record
This page lists all 424B5 filings submitted to the SEC by SELLAS Life Sciences Group, Inc. (SLS), sorted by most recent first. Each row links to the full filing on EdgarLookup. SELLAS Life Sciences Group, Inc. has filed 36 424B5 documents with the SEC since 2011. To view all SEC filings by SELLAS Life Sciences Group, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424B2
424B3
424B4
424B5
425
5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
DEL AM
EFFECT
FWP
NO ACT
NT 10-K
NT 10-Q
POS AM
POS EX
PRE 14A
PRER14A
REGDEX
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 424B5 | 424B5 | 0001104659-25-102602 | Oct 27, 2025 | — |
| 424B5 | 424B5 | 0001104659-25-007097 | Jan 29, 2025 | — |
| 424B5 | 424B5 | 0001104659-24-084492 | Aug 1, 2024 | — |
| 424B5 | 424B5 | 0001104659-24-035594 | Mar 18, 2024 | — |
| 424B5 | 424B5 | 0001104659-24-001817 | Jan 5, 2024 | — |
| 424B5 | 424B5 | 0001104659-24-001036 | Jan 4, 2024 | — |
| 424B5 | 424B5 | 0001104659-23-113381 | Nov 1, 2023 | — |
| 424B5 | 424B5 | 0001104659-23-025375 | Feb 24, 2023 | — |
| 424B5 | 424B5 | 0001104659-23-024765 | Feb 23, 2023 | — |
| 424B5 | 424B5 | 0001104659-22-041823 | Apr 1, 2022 | — |
| 424B5 | 424B5 | 0001104659-22-041078 | Mar 31, 2022 | — |
| 424B5 | 424B5 | 0001104659-20-135335 | Dec 14, 2020 | — |
| 424B5 | 424B5 | 0001104659-20-002811 | Jan 10, 2020 | — |
| 424B5 | 424B5 | 0001104659-19-057371 | Oct 30, 2019 | — |
| 424B5 | 424B5 | 0001193125-17-035049 | Feb 9, 2017 | — |
| 424B5 | 424B5 | 0001193125-16-643948 | Jul 8, 2016 | — |
| 424B5 | 424B5 | 0001193125-16-423542 | Jan 7, 2016 | — |
| 424B5 | 424B5 | 0001193125-15-091505 | Mar 13, 2015 | — |
| 424B5 | 425B5 | 0001390478-14-000076 | Nov 21, 2014 | — |
| 424B5 | 424B5 | 0001390478-14-000075 | Nov 20, 2014 | — |
| 424B5 | 424B5 | 0001390478-13-000021 | Sep 13, 2013 | — |
| 424B5 | 424B5 | 0001390478-13-000015 | Sep 12, 2013 | — |
| 424B5 | FINAL PROSPECTUS SUPPLEMENT | 0001193125-12-506811 | Dec 18, 2012 | — |
| 424B5 | PRELIMINARY PROSPECTUS SUPPLEMENT | 0001193125-12-505075 | Dec 17, 2012 | — |
| 424B5 | FORM 424(B)(5) | 0001193125-12-236354 | May 16, 2012 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001193125-12-173355 | Apr 20, 2012 | — |
| 424B5 | 424B5 | 0001193125-12-151891 | Apr 5, 2012 | — |
| 424B5 | 424B5 | 0001193125-12-150071 | Apr 4, 2012 | — |
| 424B5 | 424B5 | 0001193125-12-067741 | Feb 17, 2012 | — |
| 424B5 | 424B5 | 0000950123-11-087389 | Sep 28, 2011 | — |
| 424B5 | 424(B)(5) | 0000950123-11-035893 | Apr 15, 2011 | — |
| 424B5 | 424(B)(5) | 0000950123-11-035731 | Apr 14, 2011 | — |
| 424B5 | 424B5 | 0000950123-11-020615 | Mar 1, 2011 | — |
| 424B5 | 424B5 | 0000950123-11-019861 | Feb 28, 2011 | — |
| 424B5 | RXI PHARMACEUTICALS CORPORATION | 0000950123-10-027148 | Mar 23, 2010 | — |
| 424B5 | RXI PHARMACEUTICALS CORPORATION | 0000950123-09-027948 | Jul 31, 2009 | — |